Today before the opening
bell, Stellar Biotechnologies unveiled its new corporate website
(www.stellarbiotech.com). The new website includes streamlined, up-to-date
content on Stellar Biotechnologies’ Keyhole Limpet Hemocyanin (KHL) products,
breakthroughs in aquaculture science, and strategic expansion of its
immunotherapy program.
Stellar Biotechnologies’
Investor Relations section has also been greatly enhanced. Relevant corporate
materials are now immediately accessible online. Other available content of
interest to investors includes up-to-the-minute data, historical financial
reports, corporate news, and corporate presentations.
Mark A. McPartland, Vice
President of Corporate Development and Communications of Stellar
Biotechnologies, said, “A primary objective for Stellar is presenting key
information to stakeholders who are interested in the Company with the most
timely and well-organized material. We believe our new website achieves this
goal by accurately presenting Stellar’s industry-leading KLH technology,
products, scientific breakthroughs, expansion of our own immunotherapy program
and environmentally sustainable advantage in a user-friendly platform.”
Mr. McPartland continued, “A
main focal point of the new website is to maximize Stellar’s level of corporate
transparency for the benefit of investors and we are confident that it succeeds
in furthering this transparency. Additionally, the new website allows us to
archive an extensive range of corporate materials and information that can be
easily accessed by users at their convenience on any Internet-enabled device.”
Stellar Biotechnologies is
the world leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH),
an important immune-stimulating protein used in wide-ranging therapeutic and
diagnostic markets. KLH enjoys applications as an active pharmaceutical
ingredient in many new immunotherapies as well as a finished product for
measurement of immune status.
For more information about
how Stellar Biotechnologies is leading this field, please visit:
http://www.stellarbiotechnologies.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
